Hiromasa Yabe

Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group

Ichiro Tsukimoto, Akio Tawa, Keizo Horibe et al. · Journal of Clinical Oncology · 2009 · 233 citations · Full text

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

Seiji Kojima, Yoshiyuki Kosaka, Masuji Yamamoto et al. · Blood · 2000 · 217 citations

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

Seiji Kojima, Shigeyoshi Hibi, Yoshiyuki Kosaka et al. · Blood · 2000 · 205 citations

Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients

Asuka Hira, Hiromasa Yabe, Kenichi Yoshida et al. · Blood · 2013 · 182 citations · Full text

Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans

Felix A. Dingler, Meng Wang, Anfeng Mu et al. · Molecular Cell · 2020 · 176 citations · Full text